Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
Unit will focus on the development of sustainable biobased products and processes in the ares of chemicals and biofuels
Acquisition represents the final step in Siegfried’s targeted 5-year procurement policy
To meet growing demand for highly potent drugs, pharma companies must either face a large investment or partner with an experienced CMO. Ash Stevens says CMOs with demonstrated expertise should be at the top of the list – but what else should they offer?
Organisation highlights access campaign at Obama-Modi meeting in New York
Acquisition will generate a turnover of more than €240m for Ethypharm
Despite pressure on costs, the demand for outsourced services continues to grow, especially in the biotech sector, says Guy Tiene, That’s Nice Director of Strategic Content
Will support ideas from staff as well as from external innovators in the healthcare and life science sectors
Oral delivery of drugs remains a preferred route, and innovation in this field is at its most creative. Dr Sarah Houlton looks at some of the interesting options under development
Cambridge firm provides solid form services that are critical to successful drug discovery and development
Today, the mode of delivery can play a huge part in drug choice and success, thus new delivery technologies are proving to be a lucrative draw for drug formulators in all therapy categories. Susan Birks reports on market progress and predicted growth in the various categories
Deal includes parts of BASF's active pharmaceutical ingredients business
Advanced drug delivery systems that provide improved control over active ingredient release have become a focus for research. Aia Malik and Mark Cresswell, from Lucideon, explore the use of polymers and inorganic materials for advanced controlled release systems